Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Unique protein signature of circulating microparticles in systemic lupus erythematosus.

Østergaard O, Nielsen CT, Iversen LV, Tanassi JT, Knudsen S, Jacobsen S, Heegaard NH.

Arthritis Rheum. 2013 Oct;65(10):2680-90. doi: 10.1002/art.38065.

2.

Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation.

Nielsen CT, Østergaard O, Stener L, Iversen LV, Truedsson L, Gullstrand B, Jacobsen S, Heegaard NH.

Arthritis Rheum. 2012 Apr;64(4):1227-36. doi: 10.1002/art.34381. Epub 2012 Jan 11.

3.

Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity.

Sellam J, Proulle V, Jüngel A, Ittah M, Miceli Richard C, Gottenberg JE, Toti F, Benessiano J, Gay S, Freyssinet JM, Mariette X.

Arthritis Res Ther. 2009;11(5):R156. doi: 10.1186/ar2833. Epub 2009 Oct 15.

4.

Circulating microparticles in systemic Lupus Erythematosus.

Nielsen CT.

Dan Med J. 2012 Nov;59(11):B4548. Review.

PMID:
23171755
5.

Circulating Apoptotic Microparticles in Systemic Lupus Erythematosus Patients Drive the Activation of Dendritic Cell Subsets and Prime Neutrophils for NETosis.

Dieker J, Tel J, Pieterse E, Thielen A, Rother N, Bakker M, Fransen J, Dijkman HB, Berden JH, de Vries JM, Hilbrands LB, van der Vlag J.

Arthritis Rheumatol. 2016 Feb;68(2):462-72. doi: 10.1002/art.39417.

6.

Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus.

Nielsen CT, Østergaard O, Johnsen C, Jacobsen S, Heegaard NH.

Arthritis Rheum. 2011 Oct;63(10):3067-77. doi: 10.1002/art.30499.

7.

Galectin-3 binding protein links circulating microparticles with electron dense glomerular deposits in lupus nephritis.

Nielsen CT, Østergaard O, Rekvig OP, Sturfelt G, Jacobsen S, Heegaard NH.

Lupus. 2015 Oct;24(11):1150-60. doi: 10.1177/0961203315580146. Epub 2015 Apr 2.

PMID:
25837289
8.

Distinct proteome pathology of circulating microparticles in systemic lupus erythematosus.

Østergaard O, Nielsen CT, Tanassi JT, Iversen LV, Jacobsen S, Heegaard NHH.

Clin Proteomics. 2017 Jun 21;14:23. doi: 10.1186/s12014-017-9159-8. eCollection 2017.

9.

Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus.

Nzeusseu Toukap A, Galant C, Theate I, Maudoux AL, Lories RJ, Houssiau FA, Lauwerys BR.

Arthritis Rheum. 2007 May;56(5):1579-88.

10.

Defective expression and function of the leukocyte associated Ig-like receptor 1 in B lymphocytes from systemic lupus erythematosus patients.

Colombo BM, Canevali P, Magnani O, Rossi E, Puppo F, Zocchi MR, Poggi A.

PLoS One. 2012;7(2):e31903. doi: 10.1371/journal.pone.0031903. Epub 2012 Feb 15. Erratum in: PLoS One. 2012;7(6): doi/10.1371/annotation/1ada33bd-76c7-4b66-906f-950b383111e8.

11.

Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.

Szekanecz E, Szucs G, Szekanecz Z, Tarr T, Antal-Szalmás P, Szamosi S, Szántó J, Kiss E.

J Autoimmun. 2008 Dec;31(4):372-6. doi: 10.1016/j.jaut.2008.08.008. Epub 2008 Oct 15.

PMID:
18926664
12.

Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway.

Higgs BW, Liu Z, White B, Zhu W, White WI, Morehouse C, Brohawn P, Kiener PA, Richman L, Fiorentino D, Greenberg SA, Jallal B, Yao Y.

Ann Rheum Dis. 2011 Nov;70(11):2029-36. doi: 10.1136/ard.2011.150326. Epub 2011 Jul 28.

PMID:
21803750
14.

Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases.

Kojo S, Adachi Y, Keino H, Taniguchi M, Sumida T.

Arthritis Rheum. 2001 May;44(5):1127-38.

15.

Circulating microRNA expression profiles associated with systemic lupus erythematosus.

Carlsen AL, Schetter AJ, Nielsen CT, Lood C, Knudsen S, Voss A, Harris CC, Hellmark T, Segelmark M, Jacobsen S, Bengtsson AA, Heegaard NH.

Arthritis Rheum. 2013 May;65(5):1324-34. doi: 10.1002/art.37890.

16.

In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases.

Lorenz HM, Grünke M, Hieronymus T, Herrmann M, Kühnel A, Manger B, Kalden JR.

Arthritis Rheum. 1997 Feb;40(2):306-17.

PMID:
9041943
17.

Circulating microparticle subpopulations in systemic lupus erythematosus are affected by disease activity.

López P, Rodríguez-Carrio J, Martínez-Zapico A, Caminal-Montero L, Suárez A.

Int J Cardiol. 2017 Jun 1;236:138-144. doi: 10.1016/j.ijcard.2017.02.107. Epub 2017 Mar 1.

PMID:
28279502
18.

Serum protein profiling of systemic lupus erythematosus and systemic sclerosis using recombinant antibody microarrays.

Carlsson A, Wuttge DM, Ingvarsson J, Bengtsson AA, Sturfelt G, Borrebaeck CA, Wingren C.

Mol Cell Proteomics. 2011 May;10(5):M110.005033. doi: 10.1074/mcp.M110.005033. Epub 2011 Feb 24.

19.

Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.

Hepburn AL, Mason JC, Davies KA.

Rheumatology (Oxford). 2004 May;43(5):547-54. Epub 2004 Jan 27.

PMID:
14747618
20.

Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis.

van Eijk IC, Tushuizen ME, Sturk A, Dijkmans BA, Boers M, Voskuyl AE, Diamant M, Wolbink GJ, Nieuwland R, Nurmohamed MT.

Ann Rheum Dis. 2010 Jul;69(7):1378-82. doi: 10.1136/ard.2009.118372. Epub 2009 Nov 16.

PMID:
19919943

Supplemental Content

Support Center